BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1293@pharmaconomics
DTSTAMP:20260707T040738Z
DTSTART;VALUE=DATE:20260128
DTEND;VALUE=DATE:20260129
SUMMARY:OKYO AdCom — urcosimod
DESCRIPTION:An FDA advisory committee reviews urcosimod for neuropathic corneal pain (NCP) around Jan 28\, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1849296/000149315226004550/ex99-2.htm\n\nTrack it: https://www.pharmaconomics.com/e/1293
URL:https://www.pharmaconomics.com/e/1293
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:OKYO catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR